What happens when your Wegovy dose feels too high?

How does Wegovy's dose schedule work, and why do some steps feel too much?

Wegovy's licensed titration pathway begins at 0.25 mg once weekly and moves through 0.5 mg, 1.0 mg, and 1.7 mg before reaching the 2.4 mg maintenance dose, with roughly four weeks at each level. A higher 7.2 mg dose was approved by the MHRA in 2026 for eligible adults, extending the upper limit of what is available under UK licensing. Each step up asks the body to process more semaglutide, which increases the suppression of appetite and slows digestion further. For most people that adjustment settles within a couple of weeks. For others, especially those who are more sensitive to the medicine's gastrointestinal effects, crossing into the next dose can feel like a significant jolt.

The NHS guidance on weight-management injections is clear that the titration schedule is a guide, not a strict requirement. A prescriber can recommend staying at the same dose for an extra four weeks, or longer, if moving up is causing side effects that are genuinely disrupting daily life. That is not a failure of treatment. It is the schedule working as intended. The full Wegovy dose range and how each step is used is worth reviewing if you want to understand where you currently sit in the pathway.

One practical note: semaglutide is stored in the fridge, and some people find pulling the pen out the night before and letting it reach room temperature makes the injection itself slightly more comfortable. It will not change the dose, but comfort matters when you are already feeling rough.

What side effects suggest the current dose is too much for you right now?

Nausea is the most common complaint when a new dose steps up. It tends to peak in the first few days after an injection and ease off as the week progresses. Vomiting, diarrhoea, constipation, and persistent indigestion or reflux can also intensify after a dose increase. These effects are well documented in the clinical evidence base and, for many people, they are temporary.

The concern shifts when symptoms are severe, not settling after a week or two, or are affecting your ability to eat, drink and function. Dehydration from persistent vomiting or diarrhoea is a genuine risk that needs medical assessment rather than managing at home. The MHRA's January 2026 Drug Safety Update specifically flagged acute pancreatitis as a rare but serious risk with GLP-1 medicines: severe stomach pain that spreads to the back, with or without vomiting, needs urgent help, not a dose pause.

Milder but persistent symptoms that are affecting your quality of life are still worth raising. The question is not whether you can tolerate the current dose in theory, but whether you should. Explore what to expect in more detail on the side effects associated with higher Wegovy doses.

What are your actual options if the dose feels too high?

Your prescriber has several straightforward tools. The most common is simply repeating the current dose level for another four weeks before trying to move up again. Some patients do two or even three cycles at a step before their system adjusts, this is medically acceptable and does not compromise long-term outcomes. A step down to the previous, better-tolerated dose is also an option if the current step is causing significant problems rather than mild transient discomfort.

Anti-nausea strategies can help alongside these clinical decisions: small frequent meals, avoiding fatty or rich food around injection day, and staying well hydrated all reduce the severity of GI effects. These are general dietary adjustments, not a substitute for clinical advice, your prescriber or the Patient Information Leaflet should be your reference for what is appropriate for you specifically. You can also read about how high-dose semaglutide is managed in practice.

The NHS has produced guidance on what wrap-around support should look like alongside weight-management injections; the NHS England resource on weight-management injections covers this clearly, including advice on when to contact your clinical team. If you took a dose in error or are worried about a specific incident, the guidance on accidentally taking too high a dose of Wegovy addresses that situation directly.

When does the Wegovy dose reach its upper limit, and what does that mean?

The licensed maximum dose in the UK is currently 7.2 mg weekly, following MHRA approval of the dedicated single-dose 7.2 mg pen in April 2026. The previous standard maintenance dose of 2.4 mg remains the most widely used. A prescriber decides whether a patient is a candidate for the higher dose based on clinical review; it is not a straightforward next step available to everyone, and it is specifically licensed for adults with a BMI of 30 or above. An overview of how high the Wegovy dose can go under UK licensing sets out the current position in full.

If you are already at 2.4 mg and finding it difficult, the question of moving toward 7.2 mg is not the right one yet. Stabilising at a dose you can tolerate well tends to produce better long-term outcomes than pushing to the highest number on the schedule. Weight-loss medicines work over months and years; a cautious approach to titration is not a slower route to results, it is often a more sustainable one.

Deciding where to go from here is a clinical conversation, not something to resolve alone. Our prescribers at nume review every repeat order individually, which means your dose situation gets real clinical attention each time, not an automatic re-send. If you have questions about your current treatment, speaking to our prescribers is the right next step.